Abstract 6231: Activation of GCN2 by HC-7366 results in significant antitumor efficacy as monotherapy and in combination with multiple standard of care agents in various solid cancer modelsFeven Tameire, Nandita Bose, Sharon Huang et al.|Cancer Research|2023Cited by 3
Activation of GCN2 By HC-7366 Results in Significant Anti-Tumor Efficacy As Monotherapy and Overcomes Resistance Mechanisms When Combined with Venetoclax in AMLFeven Tameire, Nandita Bose, Nicholas Collette et al.|Blood|2023Cited by 3